Zai Lab Stock Alpha and Beta Analysis
| ZLAB Stock | USD 28.09 1.66 6.28% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Zai Lab. It also helps investors analyze the systematic and unsystematic risks associated with investing in Zai Lab over a specified time horizon. Remember, high Zai Lab's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Zai Lab's market risk premium analysis include:
Beta 0.81 | Alpha 0.65 | Risk 4.08 | Sharpe Ratio 0.17 | Expected Return 0.71 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Zai |
Zai Lab Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Zai Lab market risk premium is the additional return an investor will receive from holding Zai Lab long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Zai Lab. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Zai Lab's performance over market.| α | 0.65 | β | 0.81 |
Zai Lab expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Zai Lab's Buy-and-hold return. Our buy-and-hold chart shows how Zai Lab performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Zai Lab Market Price Analysis
Market price analysis indicators help investors to evaluate how Zai Lab stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zai Lab shares will generate the highest return on investment. By understating and applying Zai Lab stock market price indicators, traders can identify Zai Lab position entry and exit signals to maximize returns.
Zai Lab Return and Market Media
The median price of Zai Lab for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 25.33 with a coefficient of variation of 17.05. The daily time series for the period is distributed with a sample standard deviation of 4.27, arithmetic mean of 25.06, and mean deviation of 3.6. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 2500 shares by Gaynor Richard of Zai Lab at 19.5 subject to Rule 16b-3 | 09/03/2024 |
2 | Disposition of 845 shares by Yajing Chen of Zai Lab at 15.673 subject to Rule 16b-3 | 09/11/2024 |
3 | Disposition of 920 shares by Yajing Chen of Zai Lab subject to Rule 16b-3 | 10/01/2024 |
4 | Disposition of 301 shares by Yajing Chen of Zai Lab at 25.398 subject to Rule 16b-3 | 10/02/2024 |
5 | Disposition of 7145 shares by Joshua Smiley of Zai Lab subject to Rule 16b-3 | 10/11/2024 |
6 | Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024 | 10/16/2024 |
7 | Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China | 10/29/2024 |
8 | Disposition of 500 shares by Yajing Chen of Zai Lab subject to Rule 16b-3 | 11/01/2024 |
9 | Disposition of 167 shares by Yajing Chen of Zai Lab at 30.662 subject to Rule 16b-3 | 11/04/2024 |
10 | Zai Lab gets expanded Chinese approval for Vyvgart Hytrulo | 11/11/2024 |
11 | Zai Lab Ltd Reports Q3 2024 Earnings EPS Loss of 0.04, Revenue at 101. ... | 11/12/2024 |
12 | Zai Lab Announces Proposed Public Offering of American Depositary Shares | 11/13/2024 |
13 | Janus Henderson Groups Strategic Acquisition of Zai Lab Shares | 11/14/2024 |
14 | The Zai Lab Limited Third-Quarter Results Are Out And Analysts Have Published New Forecasts | 11/15/2024 |
15 | Zai Lab Ltd Awards Stock Units to Boost Employee Incentives - TipRanks | 11/19/2024 |
16 | Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO | 11/21/2024 |
About Zai Lab Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Zai or other stocks. Alpha measures the amount that position in Zai Lab has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.41 | 1.12 | 0.85 | 0.89 | Days Of Inventory On Hand | 132.41 | 155.93 | 170.76 | 249.78 |
Zai Lab Upcoming Company Events
As portrayed in its financial statements, the presentation of Zai Lab's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zai Lab's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Zai Lab's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Zai Lab. Please utilize our Beneish M Score to check the likelihood of Zai Lab's management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Zai Lab
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Zai Lab Backtesting, Zai Lab Valuation, Zai Lab Correlation, Zai Lab Hype Analysis, Zai Lab Volatility, Zai Lab History and analyze Zai Lab Performance. For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Zai Lab technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.